Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sigmoid Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Fractures, Bone 1Emergence Delirium 1Colonic Neoplasms 1

Interventions

Bismuth 6Esomeprazole 5Amoxicillin 5Tetracycline 4Oxaliplatin 4apatinib 3Irinotecan 3Furazolidone 3Fluorouracil 3Clarithromycin 3fish oil triglycerides 2Rabeprazole 2Leucovorin 2Indocyanine Green 2Berberine 2sintilimab 1potassium oxonate 1lenvatinib 1iron isomaltoside 1000 1ilaprazole 1gimeracil 1ferric carboxymaltose 1doxifluridine 1alanylglutamine 1Water 1Trastuzumab 1Tranexamic Acid 1Tobacco Use Cessation Devices 1Thalidomide 1Tegafur 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Stomach Neoplasms × Neuroleptanalgesia × Clear all
NCT05068180 2021-10-06

Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients

RenJi Hospital

Phase 4 Unknown
200 enrolled
GastrointestinalGenitourinary

Emergence Delirium, Urinary Bladder Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Liver Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Sigmoid Neoplasms, Stomach Neoplasms, Fractures, Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡